206 related articles for article (PubMed ID: 37508530)
1. First-in-Class Colchicine-Based Visible Light Photoswitchable Microtubule Dynamics Disrupting Agent.
Borys F; Tobiasz P; Fabczak H; Joachimiak E; Krawczyk H
Cells; 2023 Jul; 12(14):. PubMed ID: 37508530
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.
Wang RC; Chen X; Parissenti AM; Joy AA; Tuszynski J; Brindley DN; Wang Z
PLoS One; 2017; 12(8):e0182400. PubMed ID: 28787019
[TBL] [Abstract][Full Text] [Related]
3. Enhanced stability of microtubules contributes in the development of colchicine resistance in MCF-7 cells.
Rai A; Kapoor S; Naaz A; Kumar Santra M; Panda D
Biochem Pharmacol; 2017 May; 132():38-47. PubMed ID: 28242250
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and SAR requirements of adamantane-colchicine conjugates with both microtubule depolymerizing and tubulin clustering activities.
Zefirova ON; Nurieva EV; Shishov DV; Baskin II; Fuchs F; Lemcke H; Schröder F; Weiss DG; Zefirov NS; Kuznetsov SA
Bioorg Med Chem; 2011 Sep; 19(18):5529-38. PubMed ID: 21873068
[TBL] [Abstract][Full Text] [Related]
6. Discovery of potent microtubule-destabilizing agents targeting for colchicine site by virtual screening, biological evaluation, and molecular dynamics simulation.
Zhang H; Luo QQ; Hu ML; Wang N; Qi HZ; Zhang HR; Ding L
Eur J Pharm Sci; 2023 Jan; 180():106340. PubMed ID: 36435355
[TBL] [Abstract][Full Text] [Related]
7. Physiochemical aspects of tubulin-interacting antimitotic drugs.
Correia JJ; Lobert S
Curr Pharm Des; 2001 Sep; 7(13):1213-28. PubMed ID: 11472263
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antiproliferative activity and molecular docking of thiocolchicine urethanes.
Majcher U; Urbaniak A; Maj E; Moshari M; Delgado M; Wietrzyk J; Bartl F; Chambers TC; Tuszynski JA; Huczyński A
Bioorg Chem; 2018 Dec; 81():553-566. PubMed ID: 30248507
[TBL] [Abstract][Full Text] [Related]
9. Use of drugs to study role of microtubule assembly dynamics in living cells.
Jordan MA; Wilson L
Methods Enzymol; 1998; 298():252-76. PubMed ID: 9751887
[No Abstract] [Full Text] [Related]
10. Microtubule-active drugs suppress the closure of the permeability transition pore in tumour mitochondria.
Evtodienko YV; Teplova VV; Sidash SS; Ichas F; Mazat JP
FEBS Lett; 1996 Sep; 393(1):86-8. PubMed ID: 8804430
[TBL] [Abstract][Full Text] [Related]
11. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents.
Tangutur AD; Kumar D; Krishna KV; Kantevari S
Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738
[TBL] [Abstract][Full Text] [Related]
12. Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains.
Naaz F; Haider MR; Shafi S; Yar MS
Eur J Med Chem; 2019 Jun; 171():310-331. PubMed ID: 30953881
[TBL] [Abstract][Full Text] [Related]
13. A novel orally active microtubule destabilizing agent S-40 targets the colchicine-binding site and shows potent antitumor activity.
Du T; Lin S; Ji M; Xue N; Liu Y; Zhang Z; Zhang K; Zhang J; Zhang Y; Wang Q; Sheng L; Li Y; Lu D; Chen X; Xu H
Cancer Lett; 2020 Dec; 495():22-32. PubMed ID: 32931884
[TBL] [Abstract][Full Text] [Related]
14. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
15. Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers.
Cheung CH; Chen HH; Kuo CC; Chang CY; Coumar MS; Hsieh HP; Chang JY
Mol Cancer; 2009 Jul; 8():43. PubMed ID: 19575780
[TBL] [Abstract][Full Text] [Related]
16. Neuronal-associated microtubule proteins class III beta-tubulin and MAP2c in neuroblastoma: role in resistance to microtubule-targeted drugs.
Don S; Verrills NM; Liaw TY; Liu ML; Norris MD; Haber M; Kavallaris M
Mol Cancer Ther; 2004 Sep; 3(9):1137-46. PubMed ID: 15367708
[TBL] [Abstract][Full Text] [Related]
17. Binding of dihydroxynaphthyl aryl ketones to tubulin colchicine site inhibits microtubule assembly.
Gutierrez E; Benites J; Valderrama JA; Calderon PB; Verrax J; Nova E; Villanelo F; Maturana D; Escobar C; Lagos R; Monasterio O
Biochem Biophys Res Commun; 2015 Oct; 466(3):418-25. PubMed ID: 26365353
[TBL] [Abstract][Full Text] [Related]
18. The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization.
Prota AE; Danel F; Bachmann F; Bargsten K; Buey RM; Pohlmann J; Reinelt S; Lane H; Steinmetz MO
J Mol Biol; 2014 Apr; 426(8):1848-60. PubMed ID: 24530796
[TBL] [Abstract][Full Text] [Related]
19. Photoswitchable Inhibitors of Microtubule Dynamics Optically Control Mitosis and Cell Death.
Borowiak M; Nahaboo W; Reynders M; Nekolla K; Jalinot P; Hasserodt J; Rehberg M; Delattre M; Zahler S; Vollmar A; Trauner D; Thorn-Seshold O
Cell; 2015 Jul; 162(2):403-411. PubMed ID: 26165941
[TBL] [Abstract][Full Text] [Related]
20. Docking, synthesis and antiproliferative activity of N-acylhydrazone derivatives designed as combretastatin A4 analogues.
do Amaral DN; Cavalcanti BC; Bezerra DP; Ferreira PM; Castro Rde P; Sabino JR; Machado CM; Chammas R; Pessoa C; Sant'Anna CM; Barreiro EJ; Lima LM
PLoS One; 2014; 9(3):e85380. PubMed ID: 24614859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
